NCT05141123

Brief Summary

The aim of the study is to evaluate the outcomes of the preloaded stent-graft design (PLD) in the routine treatment of para-renal and thoraco-abdominal aneurysms. Results and postoperative events are reported in accordance with the current reporting standards for endovascular aortic repair prepared and revised by the Ad Hoc Committee for Standardized Reporting Practices in Vascular Surgery of The Society for Vascular Surgery/American Association for Vascular Surgery. The Registry will include approximately 300 patients treated from January 2015 to May 2021 (retrospective arm) and June 2021 to June 2023 (perspective arm) for the routine treatment of para-renal and thoraco-abdominal aneurysms. To reach 300 patients, the enrollments can be extended until June 2026.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
741

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2022

Shorter than P25 for all trials

Geographic Reach
8 countries

19 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 19, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 2, 2021

Completed
11 months until next milestone

Study Start

First participant enrolled

October 30, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2023

Completed
Last Updated

May 1, 2023

Status Verified

April 1, 2023

Enrollment Period

6 months

First QC Date

November 19, 2021

Last Update Submit

April 28, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical success

    absence of death, type I/III endoleak, graft infection/thrombosis, aneurysm expansion and/or rupture, conversion to open repair, or new treatment-related thoraco-abdominal pathologies

    30 days

Study Arms (1)

Preloaded Fenestrated Stent-graft Designs for Endovascular Aortic Procedures

Patients presenting with an acute (up to two weeks from the onset) and subacute (between 3 and 12 weeks from the onset) type B dissection with a proximal suitable non-dissected landing zone in the aortic arch or descending thoracic aorta (supra-aortic trunks debranching may be employed to obtain an adequate proximal landing zone)

Procedure: Complex Endovascular Aortic Procedures treated by Preloaded Fenestrated Stent-graft Designs for

Interventions

Evaluate the outcomes of the preloaded stent-graft design (PLD) in the routine treatment of para-renal and thoraco-abdominal aneurysms

Preloaded Fenestrated Stent-graft Designs for Endovascular Aortic Procedures

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will include approximately 300 patients treated from January 2015 to May 2021 (retrospective arm) and June 2021 to June 2023 (perspective arm) for the routine treatment of para-renal and thoraco-abdominal aneurysms. To reach 300 patients, the enrollments can be extended until June 2026.

You may qualify if:

  • Patients presenting with an acute (up to two weeks from the onset) and subacute (between 3 and 12 weeks from the onset) type B dissection with a proximal suitable non-dissected landing zone in the aortic arch or descending thoracic aorta (supra-aortic trunks debranching may be employed to obtain an adequate proximal landing zone

You may not qualify if:

  • Anatomy requiring sealing in the distal descending thoracic aorta may not be appropriate for a 50 cm sheath due to the risk of it being too short and the graft not reaching the intended landing zone;
  • Celiac trunk or superior mesenteric branch design that makes the graft excessively long;
  • Inability or refusal to give informed consent;
  • Simultaneously participating in another investigative device or drug study;
  • Frank rupture;
  • Systemic infection (eg, sepsis);
  • Allergy to stainless steel, polyester, solder (tin, silver), polypropylene, nitinol, or gold;
  • Untreatable reaction to contrast, which, in the opinion of the investigator, cannot be adequately premedicated.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (19)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

UMass Memorial Center for Complex Aortic Disease

Worcester, Massachusetts, 01605, United States

Location

Southwestern Medical Center, Dallas

Dallas, Texas, 75390, United States

Location

McGovern Medical School

Houston, Texas, 77030, United States

Location

University of Washington Seatle

Seattle, Washington, 98101, United States

Location

Copenhagen Aortic Center

Copenhagen, Denmark

Location

Centre Hospitalier Universitaire

Lille, France

Location

Timone Hospital Marseille

Marseille, France

Location

Centre Hospitalier Universitaire de Nantes

Nantes, France

Location

Aortic Centre Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Université Paris Saclay

Paris, France

Location

Hamburg Aortic Center

Hamburg, Germany

Location

Ludwig Maximilian University Hospital

Munich, Germany

Location

St. Franziskus Hospital

Münster, Germany

Location

Policlinico S. Orsola Malpighi

Bologna, Italy

Location

Hospital Doctor Peset

Valencia, Spain

Location

Vascular Center Malmö, Skåne University Hospital

Malmo, Sweden

Location

Department of Surgical Sciences, Vascular Surgery, Uppsala University

Uppsala, Sweden

Location

University Hospitals Birmingham NHS Foundation Trust

Birmingham, United Kingdom

Location

Kings College

London, United Kingdom

Location

Related Publications (5)

  • Greenberg RK, West K, Pfaff K, Foster J, Skender D, Haulon S, Sereika J, Geiger L, Lyden SP, Clair D, Svensson L, Lytle B. Beyond the aortic bifurcation: branched endovascular grafts for thoracoabdominal and aortoiliac aneurysms. J Vasc Surg. 2006 May;43(5):879-86; discussion 886-7. doi: 10.1016/j.jvs.2005.11.063.

    PMID: 16678676BACKGROUND
  • Mohabbat W, Greenberg RK, Mastracci TM, Cury M, Morales JP, Hernandez AV. Revised duplex criteria and outcomes for renal stents and stent grafts following endovascular repair of juxtarenal and thoracoabdominal aneurysms. J Vasc Surg. 2009 Apr;49(4):827-37; discussion 837. doi: 10.1016/j.jvs.2008.11.024. Epub 2009 Feb 23.

    PMID: 19233600BACKGROUND
  • Manning BJ, Harris PL, Hartley DE, Ivancev K. Preloaded fenestrated stent-grafts for the treatment of juxtarenal aortic aneurysms. J Endovasc Ther. 2010 Aug;17(4):449-55. doi: 10.1583/10-3024.1.

    PMID: 20681756BACKGROUND
  • Kitagawa A, Greenberg RK, Eagleton MJ, Mastracci TM. Zenith p-branch standard fenestrated endovascular graft for juxtarenal abdominal aortic aneurysms. J Vasc Surg. 2013 Aug;58(2):291-300. doi: 10.1016/j.jvs.2012.12.087. Epub 2013 Apr 20.

    PMID: 23611709BACKGROUND
  • Bisdas T, Donas KP, Torsello G, Austermann M. Technical assessment of the preloaded fenestrated stent-graft in the management of pararenal aortic aneurysms. J Endovasc Ther. 2013 Aug;20(4):461-8. doi: 10.1583/13-4310.1.

    PMID: 23914852BACKGROUND

MeSH Terms

Conditions

Aortic Aneurysm, ThoracicAortic Aneurysm, Abdominal

Condition Hierarchy (Ancestors)

Aortic AneurysmAneurysmVascular DiseasesCardiovascular DiseasesAortic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof

Study Record Dates

First Submitted

November 19, 2021

First Posted

December 2, 2021

Study Start

October 30, 2022

Primary Completion

April 20, 2023

Study Completion

April 20, 2023

Last Updated

May 1, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations